Author | Michelle A. Fanale, MD | OncLive

Author | Michelle A. Fanale, MD

Articles

Dr. Fanale on Challenges Facing Treatments in T-Cell Lymphoma

March 30, 2017

Video

Michelle A. Fanale, MD, associate professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses challenges with treatment options for patients with T-cell lymphoma.

Dr. Fanale on the Potential of Antibody-Drug Conjugates

February 12, 2013

Video

Michelle A. Fanale, MD, from the MD Anderson Cancer Center, discusses the potential of antibody-drug conjugates, as a new category of therapy for patients with cancer.

Dr. Fanale on Brentuximab Vedotin in High-Risk ALCL

January 30, 2013

Video

Michelle A. Fanale, MD, Associate Professor, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the role of brentuximab vedotin as frontline treatment of systemic anaplastic large cell lymphoma.

Dr. Fanale on Frontline Brentuximab in Lymphoma

January 16, 2013

Video

Michelle A. Fanale, MD, from the MD Anderson Cancer Center, discusses a phase I trial that examined the frontline administration of brentuximab vedotin for patients with subtypes of lymphoma.

x